SciELO - Scientific Electronic Library Online

 
vol.33 issue2Treatment options for type 2 diabetes mellitus in patients with chronic kidney disease - old and new drugsSevere passenger lymphocyte syndrome associated to Rh antibodies after donor living renal transplantation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Portuguese Journal of Nephrology & Hypertension

Print version ISSN 0872-0169

Abstract

MANO, Tânia Branco et al. Cardiovascular primary prevention - directed approach for individual features. Port J Nephrol Hypert [online]. 2019, vol.33, n.2, pp.107-114. ISSN 0872-0169.  https://doi.org/10.32932/pjnh.2019.07.022.

Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally. Despite substantial improvement in outcomes, alarming increases in obesity, diabetes mellitus and other risk factors have been noted in recent years. Despite the majority of CVD being preventable and primary prevention being cost-effective, preventive approaches are poorly implemented in the population at large as well as in individual patients. The pillar of prevention is lifestyle changes (diet, weight, smoking and exercise) followed by, when appropriate, targeting of the main cardiovascular risk factors with pharmacotherapy: lipid lowering therapy, blood-pressure treatment and blood glucose control. Low-dose aspirin as “one-dose-fits-all strategy” remains controversial as primary prevention due to the increased bleeding risk. New scoring systems or further application of imaging techniques (for example, coronary calcium score) are necessary for better risk stratification.

Keywords : cardiovascular primary prevention; cardiovascular risk factors; cardiovascular disease; lifestyle changes.

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License